Agenus
AGEN
$1.18
Share price
-0.84%
Change (1 day)
-53.91%
Change (1 year)
Categories
Agenus (AGEN) - P/B ratio
P/B ratio as of September 2023 : -5.88
According to Agenus
's latest financial reports the company has a price-to-book ratio of -5.88.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Agenus - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | -61.8 | -458.06% |
| 2021-12-31 | 17.3 | -685.47% |
| 2020-12-31 | -2.95 | 21.6% |
| 2019-12-31 | -2.42 | 48.19% |
| 2018-12-31 | -1.64 | -62.02% |
| 2017-12-31 | -4.31 | -53.05% |
| 2016-12-31 | -9.17 | -265.44% |
| 2015-12-31 | 5.55 | -48.74% |
| 2014-12-31 | 10.8 | -150.51% |
| 2013-12-31 | -21.4 | 273.68% |
| 2012-12-31 | -5.73 | 178.21% |
| 2011-12-31 | -2.06 | -73.13% |
| 2010-12-31 | -7.67 | 126.53% |
| 2009-12-31 | -3.38 | 154.44% |
| 2008-12-31 | -1.33 | -35.48% |
| 2007-12-31 | -2.06 | -57.26% |
| 2006-12-31 | -4.82 | -170.9% |
| 2005-12-31 | 6.80 | 57.14% |
| 2004-12-31 | 4.33 | 1.66% |
| 2003-12-31 | 4.26 | -2.35% |
| 2002-12-31 | 4.36 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.46 | -192.82% | 🇺🇸 USA |
 Merck MRK | 5.77 | -198.09% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.85 | -165.42% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.08 | -186.38% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | 4.36 | -174.18% | 🇺🇸 USA |